Urology of Virginia

Urology of Virginia has provided comprehensive urological care in Hampton Roads for nearly 100 years. Founded in 1922 by Charles Devine, the practice began growing in the 1950s. The practice gained an international reputation for genitourinary reconstructive surgery, developing new surgical techniques to correct urethral strictures and hypospadias that are still used today. In 1965, Urology of Virginia became one of the few private practices in the country to have a residency program. In the 1970s, we were instrumental in helping establish Eastern Virginia Medical School, Norfolk, Virginia, serving as faculty and becoming one of the first established EVMS departments.

Get in Touch

We are here to help you in anyway. Feel free to click the button below to see contact options.

Contact Us Now!
Prostate Cancer Vaccine Found Not to Improve Survival

Prostate Cancer Vaccine Found Not to Improve Survival

Prostvac-V/F, an investigational prostate cancer (PCa) vaccine regimen, does not improve overall survival among men with asymptomatic or minimally symptomatic metastatic...

 Prostate Cancer ADT Ups Osteoporotic Fracture Risk

Prostate Cancer ADT Ups Osteoporotic Fracture Risk

Men who receive androgen deprivation therapy (ADT) for prostate cancer are at elevated risk of osteoporotic fractures, new study findings confirm. The increased risk is...

 LDR Brachytherapy for PCa Yields Excellent Outcomes

LDR Brachytherapy for PCa Yields Excellent Outcomes

Low-dose-rate (LDR) brachytherapy appears to provide excellent outcomes in men treated for localized organ-confined prostate cancer (PCa), according to researchers at Mayo...

New Nocturia Classification System Proposed

New Nocturia Classification System Proposed

PHILADELPHIA—An expert panel has developed a phenotype classification system for nocturia that could provide a basis for devising diagnostic and treatment pathways for the...

ED Drugs May Not Reduce Prostate Cancer Risk

ED Drugs May Not Reduce Prostate Cancer Risk

Men who take a phosphodiesterase type 5 inhibitor (PDE5i) do not appear to have a reduced risk of prostate cancer (PCa), a new study finds. “In vitro mouse studies have...

Grapefruit-Midazolam Interaction Differs By Patient, Juice

Grapefruit-Midazolam Interaction Differs By Patient, Juice

HealthDay News — The interaction between grapefruit juice and midazolam varies based on grapefruit juice-related characteristics such as the amount of furanocoumarin, according...

 Testosterone Levels May Be Determined in Childhood

Testosterone Levels May Be Determined in Childhood

estosterone levels in men may be determined by childhood environment rather than genetics, according to new study findings published in Nature Ecology & Evolution. Kesson...

 Enzalutamide Delays Metastasis in CRPC

Enzalutamide Delays Metastasis in CRPC

Enzalutamide, an androgen receptor inhibitor, delays metastasis in men with non-metastatic, castration-resistant prostate cancer (CRPC) and a rapidly rising PSA level, according...

 Metformin Added to Prostate Cancer ADT Ups Survival

Metformin Added to Prostate Cancer ADT Ups Survival

Metformin use is associated with prolonged survival among men with advanced prostate cancer receiving androgen deprivation therapy (ADT), according to a new study. In a study...

Conservative Management Up for Low-Risk Prostate Cancer in Veterans

Conservative Management Up for Low-Risk Prostate Cancer in Veterans

(HealthDay News) -- Among US veterans with low-risk prostate cancer, use of conservative management increased from 2005 to 2015, according to a research letter published online...

 Focal HIFU Effective Over 5 Years for PCa

Focal HIFU Effective Over 5 Years for PCa

Patients who undergo focal therapy for prostate cancer (PCa) using high-intensity focused ultrasound (HIFU) experience good survival over 5 years, according to new study...

Erectile Dysfunction Associated With Subclinical Myocardial Injury

Erectile Dysfunction Associated With Subclinical Myocardial Injury

HealthDay News — Erectile dysfunction is tied to higher circulating concentrations of high-sensitivity cardiac troponin I (hs-cTnI), indicating subclinical myocardial injury,...